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The comparative gene identiﬁcation-58 (CGI-58) gene, mutations of which are linked to Chanarin-
Dorfman syndrome, encodes a protein of the a/b hydrolase domain subfamily. We report here a
new alternative splicing isoform of the murine CGI-58 gene, termed mCGI-58S. Sequence compari-
son indicates the lack of second and third exons in this cDNA variant. While the full-length protein
displayed perilipin-dependent localization to lipid droplets, mCGI-58S showed a predominant cyto-
plasmic staining when expressed in cells. mCGI-58S was incapable of activating adipose triglyceride
lipase but retained the capacity to acylate lysophosphatidic acid. Overexpression of mCGI-58S failed
to promote lipid droplet turnover and loss of intracellular triacylglycerols. These results suggest that
this splicing event may be involved in the regulation of lipid homeostasis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction A major advance in understanding the function of CGI-58 wasChanarin-Dorfman syndrome (CDS) is a rare form of neutral li-
pid storage disease (NLSD) characterized by the accumulation of
cytosolic lipid droplets containing triacylglycerol (TAG) in various
tissues such as skin and liver as well as isolated cells including
lymphocytes, macrophages and ﬁbroblasts [1–4]. CDS is also
termed NLSD with itchyosis (NLSDI) due to the ﬁne white scaling
phenotype associated with the impaired barrier function of the
skin [3]. Earlier studies using ﬁbroblasts obtained from CDS pa-
tients indicated a defect in the recycling of TAG-derived products
such as mono- and diacylglycerols to glycerophospholipids [5,6].
A defect in the catabolism of TAG harboring long acyl chains was
also shown in CDS ﬁbroblasts [7]. In 2001, Lefevre et al. identiﬁed
mutations of CGI-58 (comparative gene identiﬁcation-58; also
known as a/b hydrolase fold-containing protein 5, ABHD5) as caus-
ative for CDS [8]. Separate studies demonstrated that in adipocytes
CGI-58 was localized to lipid droplets via binding directly to perili-
pin [9,10]. However, the biochemical roles of CGI-58 in lipid
metabolism and the mechanisms whereby mutations of CGI-58
lead to CDS remained unclear.chemical Societies. Published by E
ﬁcation-58; CDS, Chanarin-
A, phosphatidic acid; ATGL,
ediatrics, University of Ken-
ington, KY 40536-0509, USA.the discovery that the lipase activity of adipose triglyceride lipase
(ATGL), the rate limiting enzyme for TAG catabolism, is highly
dependent on the association with CGI-58 [11]. CGI-58 contains a
canonical lipase motif, although the usual catalytic serine in
GXSXG motif is replaced by asparagine. As a result, CGI-58 itself
does not have a lipase activity. Upon interaction with CGI-58, ATGL
TAG lipase activity increased up to 20-fold in cultured cells. Inter-
estingly, CGI-58 mutants associated with CDS failed to activate
ATGL [11], implicating that loss of ATGL activation may be involved
in the pathogenesis of CDS. Overexpression of either ATGL or
CGI-58 alone in COS-7 cells did not affect TAG storage, whereas
overexpression of both proteins markedly reduced TAG deposition,
indicating that the interaction between ATGL and CGI-58 is
required for efﬁcient lipolysis. In accordance with the role of
CGI-58 in ATGL activation, silencing of CGI-58 expression was
found to drastically reduce PKA-activated FA and glycerol release
in both mouse 3T3-L1 [11] and human hMADs adipocytes [12].
Aside from its role in lipolysis, CGI-58 was recently identiﬁed as
closely related to ICT1 [13], a yeast acyltransferase responsible for
enhanced phospholipid synthesis [14]. Consistently, sequence anal-
ysis reveals thatCGI-58possess a C-terminalHX4Dmotif common to
proteins with acyltransferase activity. Like ICT1, CGI-58 was shown
to be able to convert lysophophatidic acid (LPA) to phosphatidic acid
(PA) in an acyl-CoA-dependent manner. Interestingly, overexpres-
sion of human CGI-58 in yeast showed an increase in the formation
of PA along with an overall increase of total phospholipids [13].
Based upon these observations, it has been proposed that inlsevier B.V. All rights reserved.
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recycling of TAG-hydrolyzed products into phospholipids, thereby
maintaining the TAGbalance inmammalian systems [13]. However,
mutations of CGI-58 causal for CDS did not affect its activity as LPA
acyltransferase [13], indicating that pathogenesis of CDS is not ac-
counted for by the loss of such activity of CGI-58.
In the process of analyzing the expression of murine CGI-58, we
found a shorter CGI-58 cDNA generated by alternative splicing.
This splicing variant eliminates the second and the third exons,
producing a protein unable to activate ATGL, but still able to func-
tion as a LPA acyltransferase. Thus, it could play a unique role in
the regulation of TAG and phospholipid metabolism.2. Materials and methods
2.1. Cell culture
HeLa cells (ATCC) were cultured in DMEM containing 10% fetal
bovine serum (FBS). Mouse 3T3-L1 preadipocytes were maintained
in DMEM supplemented with 10% newborn calf serum, 100 U/ml
penicillin G sodium, and 100 lg/ml streptomycin sulfate. Differen-
tiation to adipocytes was induced by treatment of postconﬂuent
cells with 10% FBS, 1 lg/ml insulin, 1 lM dexamethasone (DEX),
and 0.5 mM isobutyl-1-methylzanthine (IBMX). The differentiation
medium was withdrawn 3 days later and replaced with medium
supplemented with 10% FBS and 1 lg/ml insulin. After 2 days in
insulin containing medium, the cells were then cultured in DMEM
containing 10% FBS.
2.2. RNA extraction, PCR cloning of cDNA and construction of plasmids
Total RNA was prepared from mouse 3T3-L1 preadipocytes and
adipocytes using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s instruction. cDNA was prepared from mRNA using
SuperScript Reverse Transcriptase protocol (Invitrogen). RNA was
extracted from mouse tissue as described above. The sequences
containing the complete open reading frame of mouse CGI-58
and shorter CGI-58 were ampliﬁed by PCR using ultra Pfu DNA
Polymerase Mix (Stratagene). The primers designed to create
restriction sites for subsequent cloning strategies are as follows:
primer 1, CGI-58 forward (50-GCG GAT CCA AAG CGA TGG CGG
CGG AGG AGG-30); primer 2, CGI-58 reverse (50-CGC TCG AGT
CAG TCT ACT GTG TGG CAG ATC-30).
The PCR products containing CGI-58FL and CGI-58S cDNA were
cleaved by BamHI/XhoI. The digested products were puriﬁed and
ligated in frame to BamHI (50) and XhoI (30) sites of the eukaryotic
expression vector of pKMyc to generate constructs with a Myc epi-
tope tag fused to the 50 end of the cDNAs.
2.3. Transient transfection of HeLa cells and 3T3-L1 adipocytes
Transient transfection of HeLa cells was performed using Lipo-
fectamine 2000 reagent according to the manufacturer’s instruc-
tions. For immunoﬂuorescence studies, 0.5 lg of each DNA
construct was transfected into cells cultured on coverslips at low
density in 6-well dishes. Cells were ﬁxed 16–18 h post transfec-
tion. For immunoblotting analysis, 1.0 lg of each DNA was used
in transfection of subconﬂuent cells cultured in 60-mm dishes.
Cells were lysed 16–18 h post transfection. 3T3-L1 adipocytes were
transfected by electroporation as described previously [15].
2.4. Cell lysis and immunoblotting
For immunoblotting, HeLa cells were washed twice with ice-
cold PBS, and were lysed at 4 C with a buffer containing 50 mMTris–HCl (pH 8.0), 135 mM NaCl, 10 mM NaF, 1% NP-40, 0.1%
SDS, 0.5% sodium deoxycholate, 1.0 mM EDTA, 5% glycerol and
protease inhibitors (1 tablet per 7 ml of buffer). The lysates were
clariﬁed by centrifugation at 10000g for 10 min and then
mixed with equal volume of 2 SDS sample buffer. The solubi-
lized proteins were resolved by SDS–PAGE and transferred to
nitrocellulose membranes. Individual proteins were blotted with
primary antibodies against ATGL (Cell Signaling, 1:3000) or Myc
(Santa Cruz Biotech., 1:3000) at appropriate dilutions. Peroxide-
conjugated secondary antibodies were incubated with the
membrane at a dilution of (1:5000). The signals were then visu-
alized by enhance chemiluminescence (ECL Reagents, GE
Healthcare).
2.5. Immunoﬂuorescence staining and confocal microscopy
HeLa cells and adipocytes were maintained at proper densities
on glass coverslips placed in 6-well dishes. Following the ﬁxation
with 3% paraformaldehyde in PBS for 30 min and permeabilization
with 0.5% Triton X-100 in PBS for 5 min, cells were quenched with
100 mM glycine in PBS for 20 min and then blocked with 1% BSA in
PBS for 1 h. The cells were then exposed to Myc and/or perilipin
(Abcam) antibodies (1:1000) for 2 h at room temperature. Follow-
ing three washes with PBS, the cells were treated for 1 h in block-
ing solution with Alexa Fluor secondary antibodies diluted to 2 lg/
ml. To visualize lipid droplets, BODIPY 493/503 dye was added at
a ﬁnal concentration of 0.3 lg/ml during the incubation with
secondary antibodies. Samples were mounted on glass slides with
Vectashield mounting medium with DAPI and examined under a
Leica SP5 inverted confocal microscope.
2.6. In vitro transcription-and-translation expression and TAG
hydrolase activity assay
In vitro transcription/translation was carried out by using TNT
SP6 High-Yield Protein Expression System according to the manu-
facture’s instruction. Speciﬁcally, 10 lg vector DNA per reaction
was used to produce ATGL, CGI-58FL and CGI-58S for TAG hydro-
lase assays. The TAG hydrolase activity against 3H-labled triolein
was measured as described previously [11,16]. A total of 35 ll of
reaction mixture were pre-diluted with 65 ll of cell extraction buf-
fer. The resulting 0.1 ml of reaction mixture was then combined
with 0.1 ml of substrate solution in the TAG hydrolase activity
measurement.
2.7. LPA acyltransferase assay
This assay was performed as described previously [13,14].
Brieﬂy, the reaction mixture contained 50 lM 1-oleoyl-[oleoyl-
9,10-3H] LPA (220000dpm/assay) and 20 mM acyl-CoA in lysis buf-
fer containing of Tris–HCL (pH 8.0) and 300 mM NaCl with a total
volume of 100 ll The reaction was carried out at 30 C for 10 min.
The lipids were separated on a TLC plate using chloroform:metha-
nol:acetone:acetic acid:water (50:10:20:15:5, v/v/v/v/v) as the sol-
vent system. The TLC plates were air dried and subjected to
autoradiography.
2.8. Measurement of intracellular TAG content
TAG accumulation was measured using a triglyceride assay kit
(Zenbio). Brieﬂy, HeLa cells plated in 24-well dishes were washed
and lysed in provided lysis buffer. The triglyceride assay reagents
were added according to the manufacturer’s instructions. The opti-
cal density of the mixture was measured at 540 nm using a spec-
trophotometer plate reader.
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Fig. 1. Identiﬁcation of a new alternatively spliced murine CGI-58. (A) RT–PCR ampliﬁcation of murine mRNAs from preadipoctes and adipocytes. (B) RT–PCR analysis of
mouse adipose, liver and pancreas RNA. RT was performed with random priming and equivalent aliquots of cDNA were used for PCR ampliﬁcation. The 1053 bp cDNA
corresponds to the full-length murine CGI-58 (GeneBank accession number NM_026179); the 594 bp cDNA was identiﬁed as a novel spliced CGI-58 variant. (C) A schematic
picture of murine CGI-58 genomic structure and its putatived transcripts. Black boxes represent the 50 and 30 untranslated regions. (D) Murine CGI-58S cDNA sequence with
coding sequences capitalized. Square box shows the alternative spliced region encoded by exon 2 and exon 3. Underlined sequence is a putative lipid binding domain. The
conserved GXNXGmotif and HX4Dmotif are indicated in bold in black and grey areas, respectively. Histidine (H329) and the putative third residue of the catalytic triad, either
glutamate (E262) or aspartate (D303) are indicated by double underlines. (E) Transient expression of proteins in HeLa cells was analyzed by immunoblotting with anti-Myc
antibody.
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3.1. Alternatively spliced variant of murine CGI-58 gene
During the analysis of CGI-58 expression by RT–PCR, we de-
tected two distinct CGI-58 transcripts in murine 3T3-L1 preadipo-cytes and adipocytes, the expected CGI-58 full-length messenger
and a shorter fragment not described previously (Fig. 1A). A sepa-
rate RT–PCR ampliﬁcation conﬁrmed the existence of the same
variants in mouse tissues such as liver, pancreas and fat, though
the ratio of expression between the two appears to vary depending
on the speciﬁc tissue type (Fig. 1B). Since PCR reactions were
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Fig. 2. Lipid droplet localization of murine GGI-58 isoforms. (A) HeLa cells transfected with Myc-CGI-58FL or Myc-CGI-58S were incubated under normal growth conditions
with 400 lM of oleic acid complexed to albumin for 3 h. Immunoﬂuorescence staining with anti-Myc antibody (red) was performed to reveal the respective proteins, Myc-
CGI-58FL (upper panel) or Myc-CGI-58S (lower panel). Lipid droplets were co-stained with BODIPY 493/503 ﬂuorescence dye (green). (B) Perilipin was coexpressed with
either Myc-CGI-58FL or Myc-CGI-58S in HeLa cells. Cells were treated with oleic acid as in (A), and co-stained with Myc (red) and perilipin (green) antibodies. (C)
Overexpression of CGI-58FL or CGI-58S in adipocytes was achieved via electroporation. Immunoﬂuorescence staining with Myc antibody (green) was analyzed 3 days later.
906 X. Yang et al. / FEBS Letters 584 (2010) 903–910carried out using speciﬁc primers complementary to sequences
containing the 50 translation start site and the 30 stop codon of
murine CGI-58 cDNA (primers 1 and 2, see Section 2), we thought
that a process of alternative splicing could account for the genera-
tion of this novel fragment. To check this hypothesis, both PCR
products were sequenced. While the major PCR fragment of 1053
bp is identical with the published CGI-58 cDNA, the minor frag-
ment of 594 bp lacks an internal sequence of 495 bp within the
50 region of the full-length sequence (GeneBank accession number
NM_026179). This structure strongly suggests that this shortened
cDNA molecule represents a new spliced variant of murine CGI-
58. Alignment analysis using BLAST program (NCBI) with mouse
genomic and cDNA sequences of CGI-58 indicates that ﬂanking
nucleotides of divergence point among sequences of this 594 bpfragment perfectly match with exonic sequences from exon1/in-
tron1 and intron3/exon4 junctions, conforming that entire exon 2
and exon 3 are spliced out in the shorter fragment (Fig. 1C). This
result shows that a splicing event is involved in the generation of
this CGI-58 variant that includes the ﬁrst ATG-containing exon fol-
lowed by exons 4–7. We have named this novel mouse CGI-58 iso-
form mCGI-58S as opposed to the full-length version which we
refer to as mCGI-58FL.
The mCGI-58FL is a 351-amino acid protein. Like its human
orthologue, mCGI-58FL belongs to a/b hydrolase family. The a/b
hydrolase fold is localized between amino acids 104 and 345 of
mCGI-58FL. The protein contains a ‘‘pseudo-catalytic triad” at posi-
tions 153(Asn)/327(His)/301(Asp), with the nucleophilic serine
usually found in the typical GXSXG motif being replaced by an
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Fig. 3. Effects of CGI-58 isoforms on TAG hydrolase activity or LPA acyltransferase
activity. ATGL, mCGI-58FL and mCGI-58S produced by using in vitro translation
system. (A and B) Protein were mixed and then subjected to immunoblotting
analysis with ATGL and Myc antibodies (A) and TAG hydrolase activity assays (B).
The TAG hydrolase activity in the cell lysate was measured using 3H-labeled triolein
as substrate. The activity was expressed as fold difference compared to activity in
extracts containing ATGL-alone. Data are shown as mean ± S.D. and represent three
independent experiments. (C) LPA acyltransferase activity was monitored under the
standard assay conditions with equivalent amounts of proteins.
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tains a putative lipid binding domain between amino acids 72
and 90 that is highly hydrophobic, and a HX4D motif between ami-
no acids 335 and 340 that is present in proteins with acyltransfer-
ase activity [13,17]. As shown Fig. 1D, the predicted open reading
frame of CGI-58S encodes for a 202-amino acid protein that lacks
the lipid binding domain and the GXNXG motif. However, the
HX4D motif for acyltransferase activity is retained in mCGI-58S,
suggesting that this splicing variant may still function as a LPA
acyltransferase as the full-length protein.
3.2. Lipid droplet localization of mCGI-58FL vs. mCGI-58S
In an attempt to identify the functional differences between
mCGI-58S and its full-length counterpart, we decided to examine
their lipid droplet localization in non-adipocyte cells and adipo-
cytes. Both proteins were tagged with a Myc epitope tag at the
N-terminus, and immunoblotting analysis conﬁrmed the size of
the proteins when expressed in HeLa cells (Fig. 1E). After a pro-
longed treatment with oleic acid to enhance lipid droplet forma-
tion, cells were ﬁxed and subjected to immunoﬂuorescence
staining with speciﬁc anti-Myc antibodies. Lipid droplets were
co-stained with a BODIPY non-polar ﬂuorescence dye that is selec-
tive for neutral lipids including TAG. As shown in Fig. 2A upper pa-
nel, Myc-mCGI-58FL alone displayed a diffusive distribution
throughout the cytoplasm, with a very low level of staining at
the surface of lipid droplets. Coexpression of perilipin promoted
the lipid droplet localization of mCGI-58L (Fig. 2B, upper panel),
consistent with the conclusion derived from previous studies that
interaction with perilipin plays a critical role in recruiting CGI-58
to lipid droplets [9,10]. In comparison, Myc-mCGI-58S alone exhib-
ited a punctuate pattern of localization that did not overlap with
lipid droplets (Fig. 2A, lower panel). Interestingly, coexpression of
perilipin conferred no effect on this localization of mCGI-58S
(Fig. 2B, lower panel). Similar results were obtained from overex-
pression studies using 3T3-L1 adipocytes. As shown in Fig. 2C,
ectopic mCGI-58S failed to localize to lipid droplets, whereas the
full-length protein showed a clear presence at the surface of lipid
droplets along with a punctuate distribution in the cytoplasm.
Taken together, these results suggest that the region encoded by
exons 2 and 3 and missing in mCGI-58S is required for the perili-
pin-dependent localization to lipid droplets.
3.3. CGI-58S is not a coactivator of ATGL lipase activity
The TAG lipase activity of ATGL is largely dependent on the pres-
ence of CGI-58 [11,18]. To test whether mCGI-58S would also work
as a coactivator of ATGL, we assayed the enzyme activity of ATGL
using a cell free system in the presence of either mCGI-58FL or
mCGI-58S. Myc-CGI-58FL, Myc-CGI-58S and ATGL were prepared
separately by an in vitro transcription/translation method employ-
ing wheat germ extracts. These proteins were efﬁciently produced
at comparable levels as revealed by anti-Myc immunoblotting of
the resultant extracts (Fig. 3A). In the subsequent enzymatic assays
using triolein as substrate, the addition of CGI-58FL-containing ex-
tracts to ATGL-containing extracts resulted in an over seven-fold in-
crease in the lipase activity when compared to ATGL extracts alone
(Fig. 3B). By contrast, CGI-58Swas incapable of signiﬁcantly activat-
ing ATGLwhen their respective extracts were combined. To assess if
the presence of mCGI-58S would inﬂuence the ability of the full-
lengthprotein to activateATGL, the extracts containingall threepro-
teinsweremixedprior to the initiationof the lipaseenzymereaction.
As shown in Fig. 3B,mCGI-58FL activatedATGL to the samedegree in
the presence as compared to in the absence of mCGI-58S, indicating
that the shorter variant does not interfere with the full-length pro-
tein in the augmentation of ATGL activity.3.4. CGI-58S retains LPA acyltransferase activity
Previous work by Gosh et al. has shown that CGI-58 exhibits
acyl-CoA-dependent acyltransferase activity for LPA, leading to
the generation of PA [13]. Since mCGI-58S retains the HX4D motif,
we asked whether mCGI-58S would still function as a LPA acyl-
transferase as the full-length protein. In this regard, Myc-CGI-
58FL and Myc-CGI-58S proteins were prepared by the in vitro
transcription/translation, and their LPA acyltransferase activity
was measured in the resultant extracts by using the established
method [13]. As shown in Fig. 3C, the two proteins were equally
effective in mediating the formation of PA via the incorporation
of oleoyl-CoA into LPA. Thus, the shorter variant of mCGI-58 indeed
possesses LPA acyltransferase activity.
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Fig. 4. Effects of GGI-58 isoforms on intracellular TAG content and lipid droplet degradation. (A) Left panel: HeLa cells were transfected with vector alone (V), Myc-CGI-58FL
(L) or Myc-CGI-58S (S). Immunoﬂuorescence staining with anti-Myc antibody (red) was performed to reveal the transfected cells. Nuclei were co-stained with DAPI
ﬂuorescence dye (blue). Right panel: Following transfection, cells were incubated under normal growth conditions with 400 lM of oleic acid complexed to albumin for 24 h
(white bars). A separate set of cells were incubated in serum- and glucose-free medium for 4 h following 24 h of incubation with 400 lM of oleic acid complexed to albumin
(grey bars). The TAG content was determined as described in Section 2. Data are shown as mean ± S.D. and represent three independent experiments. (B) HeLa cells
transfected with Myc-CGI-58FL or Myc-CGI-58S were mixed with untransfected cells followed by treatment with oleic acid for 24 h. Immunoﬂuorescence staining with Myc
antibody (red) was performed, and lipid droplets were co-stained with BODIPY 493/503 ﬂuorescence dye (green). (C) Same experiments as in (B) except that cells were
incubated in serum- and glucose-free medium for 4 h following 24 h of oleic acid treatment.
908 X. Yang et al. / FEBS Letters 584 (2010) 903–9103.5. Effects of CGI-58S on TAG content and lipid droplet degradation
The impact of mCGI-58FL vs. mCGI-58S on intracellular TAG
content was assessed by comparing the cellular TAG levels and
the lipid droplet morphology in HeLa cells. Cells were transfected
with vector alone, mCGI-58FL or mCGI-58S with comparable efﬁ-
ciencies as revealed by anti-Myc immunostaining and counter
staining of nuclei with DAPI dye. For the measurement of intracel-
lular TAG content, transfected cells were ﬁrst treated with oleic
acid to promote TAG accumulation. In comparison to transfectionwith vector alone, mCGI-58FL slightly decreased while mCGI-58S
slightly increased intracellular TAG content (Fig. 4A). Interestingly,
in response to nutrient withdrawal following the oleic acid treat-
ment, cells expressing mCGI-58FL exhibited a more drastic loss
of intracellular TAG than those transfected with vector alone. On
the other hand, expression of mCGI-58S did not promote such loss
of TAG induced by the nutrient withdrawal. For studies of lipid
droplets degradation, untransfected cells were mixed with cells
either expressing mCGI-58FL or mCGI-58S. As shown in Fig. 4B,
overloading cells with oleic acid resulted in accumulation of large
X. Yang et al. / FEBS Letters 584 (2010) 903–910 909lipid droplets in both transfected cells and neighboring untransfec-
ted cells. No obvious difference in size and number of lipid droplets
were observed in untransfected cells and cells expressing either
mCGI-58FL or mCGI-58S. However, upon nutrient withdrawal, li-
pid droplets in cells expressing mCGI-58-FL underwent more pro-
nounced degradation than those in untransfected cells. In
comparison, expression of mCGI-58S did not enhance the turnover
of lipid droplets. Collectively, these results suggest that the shorter
variant of CGI-58 does not share the function of the full-length pro-
tein in the regulation of TAG catabolism.4. Discussion
In humans,mutations of CGI-58/ABHD5 are associatedwith CDS,
characterized by excessive accumulation of TAG in multiple tissues
and ichthyosis [1–4]. Sequence comparison of human CGI-58 and
the murine orthologue reveals 94% identity and 96% homology,
implying that they are functionally interchangeable. In this study,
we describe that alternative splicing generates a novel shorter cDNA
variant molecule of murine CGI-58, which we have named CGI-58S.
Like the full-length isoform, CGI-58S is expressed in cultured 3T3-L1
adipocytes as well as in tissues such as fat, liver and pancreas, sug-
gesting that it could be functionally relevant in various settings. Pre-
viously Northern analyses of CGI-58 inmouse tissues have revealed
two mRNA speciﬁes of 1.4 and 3.2 kb, which presumably vary in
the length of their 30 untranslated regions [10,11]. It is possible that
themRNA of CGI-58S, whichwas detected by RT–PCR ampliﬁcation,
has not been identiﬁed earlier by Northern analysis due to its low
expression level relative to the full-length mRNA.
The biochemical functions of CGI-58 protein had been largely
unclear until the discovery of CGI-58 as a potent coactivator of
ATGL [11]. Interestingly, mCGI-58S, lacking a sequence of 143 ami-
no acids encoded by exons 2 and 3, does not share this role of the
full-length protein in lipolysis. In HeLa cells, overexpression CGI-
58S did not promote either turnover of lipid droplet or decrease
in intracellular TAG as compared to CGI-58FL. Moreover, in a stan-
dard TAG lipase assay against triolein substrate, CGI-58S exhibited
no activating effect on ATGL, while CGI-58FL was able to enhance
ATGL activity by 7–8-folds. Furthermore, it is unlikely that CGI-
58S would directly inﬂuence CGI-58FL in the regulation of lipolysis.
This notion is supported by the observations that CGI-58S is inca-
pable of localizing onto lipid droplets, and the presence of CGI-58S
did not affect the activation of ATGL by CGI-58FL in vitro. Although
the mechanisms by which the full-length CGI-58 regulates ATGL
remains elusive, we speculate that the absence of three structural
features in mCGI-58S, namely the putative lipid binding motif, the
GXNXG ‘‘pseudo esterase/lipase” motif and Gln130, may explain its
inability to activate ATGL. While the functional contribution of the
lipid binding sequence and the GXNXG motif remain uncharacter-
ized, the Gln130 is known to be important for the interaction with
ATGL [9]. The Q130P mutation, causal for CDS, was shown previ-
ously to completely eliminate the ATGL-activating capacity of the
full-length CGI-58 [11].
CGI-58 was previously shown to localize to lipid droplets via its
interaction with perilipin in adipocytes and with ADRP/adipophilin
in non-adipocyte cells [9,10]. In a recently proposedmodel of adipo-
cyte lipolysis [4,19], CGI-58 binds to perilipin on the surface of lipid
droplets and is unable to activate ATGL in the basal state. Upon
b-adrenergic stimulation, CGI-58 dissociates from phosphorylated
perilipin and complexes with ATGL, thereby activating lipolysis. In
our hands, CGI-58S displayed a different subcellular distribution
from CGI-58FL when overexpressed in cultured cells. In 3T3-L1 adi-
pocytes that express a high level of endogenous perilipin, CGI-58FL
was expectedly localized on the surface of lipid droplets, whereas
CGI-58S resided predominantly in the cytoplasm. Notably, CGI-58FL also displayed a punctuate localization in the cytoplasm in
addition to lipid droplets. Since ATGL resides in an ER-relatedmem-
brane compartment when not localized to lipid droplets [20], we
speculate that CGI-58FLmay occur in associationwith similarmem-
brane structures. The speciﬁc involvement of perilipin in the lipid
droplet localizationofCGI-58was later evaluatedbya reconstitution
experiment using HeLa cells that express no endogenous perilipin.
When expressed alone in HeLa cells, neither CGI-58FL nor CGI-58S
showed noticeable localization to lipid droplets.
Similar to what was observed in 3T3-L1 preadipocytes [10],
adipophilin at the endogenous level apparently failed to efﬁciently
recruit CGI-58FL to the lipid droplets in HeLa cells. Interestingly,
the addition of perilipin in HeLa cells via coexpression resulted in
a profound recruitment of CGI-58FL to the lipid droplets. However,
the ectopic perilipin had no effect on the localization of CGI-58S.
The ﬁndings are in accordance with the notion that nearly the en-
tire region of CGI-58 is required for the co-localization with perili-
pin on the surface of lipid droplets. Since CGI-58S lacks the
putative lipid binding motif, it remains to be determined whether
the loss of lipid droplet localization of CGI-58S is due to its inability
to bind perilipin or to interact directly with lipids or both.
CGI-58 was recently demonstrated to exhibit activity as an acyl-
CoA-dependent LPA acyltransferase [13]. Although the in vivo rel-
evance of this ﬁnding is still unknown, the acyltransferase activity
of CGI-58 is postulated to facilitate recycling of products derived
from TAG hydrolysis into glycerophospholipids [13]. Thus, CGI-58
may function in both lipolysis and synthesis of phospholipids,
depending on its subcellular localization. Our data demonstrated
that mCGI58S, with an intact HX4D motif, possessed a similar
LPA acyltransferase activity as the full-length protein. Since it is
predominantly localized in the cytoplasm, CGI-58S probably
mainly function as a LPA acyltransferase in the production of PA.
PA is common precursor for both TAG and glycerophopholipids,
and its ﬁnal fate may be decided by the lipolytic status in the cells.
In this regard, it is tempting to speculate that LPA acylation medi-
ated by CGI-58S and TAG hydrolysis driven by CGI-58FL may work
coordinately to facilitate net ﬂux of PA to phospholipids.
In summary, the present study highlights the existence of a no-
vel splicing variant of CGI-58 in mouse. This splicing event may
potentially be involved in the regulation of intracellular lipid
homeostasis. Thus, it would be interesting to determine if such
splicing is subject to regulation by speciﬁc hormonal and/or nutri-
tional conditions. Moreover, no equivalent alternative spliced iso-
form to mCGI-58S has been described in other species including
human. It is possible that in other mammals, alternative mecha-
nisms would account for generating a functional counterpart of
mCGI-58S. Furthermore, our ﬁndings provide valuable information
to functional studies of CGI-58, most of which have employed
mouse cell lines such as 3T3-L1 adipocytes and genetically modi-
ﬁed mice.
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